Lensar Inc Down 9.45% To $2.30 After Earnings

Lensar Inc (LNSR) said before open Monday that it broke even in quarter one 2023.

In the same quarter a year ago, the company lost $0.67 per share on revenue of $9.3 million.

The stock is down 9.45% to $2.30 after the report.

The firm's lower revenue growth to earnings signals that the firm has been able to reduce costs and improve its profit margin overall.

InvestorsObserver gives the stock a Bearish Sentiment score at the moment based on recent trading.

Lensar Inc has performed poorly during the past few months, garnering a low Long-Term Technical Rank by InvestorsObserver of 13, putting Lensar Inc in the bottom 25% of stocks. The firm was recently trading at a 52-week low of $1.9 on March 23, 2023 and set a 52-week high on May 16, 2022 at $7.98.

LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit.